Alaa Muslimani

449 total citations
27 papers, 275 citations indexed

About

Alaa Muslimani is a scholar working on Oncology, Hematology and Internal Medicine. According to data from OpenAlex, Alaa Muslimani has authored 27 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Hematology and 6 papers in Internal Medicine. Recurrent topics in Alaa Muslimani's work include Venous Thromboembolism Diagnosis and Management (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Alaa Muslimani is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Alaa Muslimani collaborates with scholars based in United States. Alaa Muslimani's co-authors include Hamed Daw, Donald C. Moore, Timothy P. Spiro, Harris C. Taylor, Eric K. Singhi, Manmeet S. Ahluwalia, Sebouh Setrakian, Madappa N. Kundranda, Ishmael Jaiyesimi and Girish B. Nair and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Hematology.

In The Last Decade

Alaa Muslimani

27 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alaa Muslimani United States 10 103 86 74 73 41 27 275
Philip Bennett United Kingdom 9 89 0.9× 51 0.6× 48 0.6× 77 1.1× 55 1.3× 22 339
Ülkü Yalçıntaş Arslan Türkiye 11 147 1.4× 223 2.6× 106 1.4× 86 1.2× 20 0.5× 52 470
Xiaofang Li China 10 60 0.6× 35 0.4× 40 0.5× 88 1.2× 37 0.9× 32 317
R. Grace United Kingdom 8 53 0.5× 68 0.8× 128 1.7× 106 1.5× 33 0.8× 17 352
J.L. Balibrea Spain 12 106 1.0× 150 1.7× 72 1.0× 138 1.9× 143 3.5× 18 562
Hideyuki Koharazawa Japan 12 52 0.5× 115 1.3× 96 1.3× 38 0.5× 47 1.1× 40 405
Stefano Mancini Italy 9 60 0.6× 60 0.7× 38 0.5× 136 1.9× 14 0.3× 27 419
Sabine Kroiss Switzerland 12 126 1.2× 31 0.4× 64 0.9× 68 0.9× 34 0.8× 22 460
Hiroki Mizuno Japan 11 94 0.9× 118 1.4× 63 0.9× 72 1.0× 17 0.4× 106 454

Countries citing papers authored by Alaa Muslimani

Since Specialization
Citations

This map shows the geographic impact of Alaa Muslimani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alaa Muslimani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alaa Muslimani more than expected).

Fields of papers citing papers by Alaa Muslimani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alaa Muslimani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alaa Muslimani. The network helps show where Alaa Muslimani may publish in the future.

Co-authorship network of co-authors of Alaa Muslimani

This figure shows the co-authorship network connecting the top 25 collaborators of Alaa Muslimani. A scholar is included among the top collaborators of Alaa Muslimani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alaa Muslimani. Alaa Muslimani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moore, Donald C., et al.. (2019). Fostamatinib for the treatment of immune thrombocytopenia in adults. American Journal of Health-System Pharmacy. 76(11). 789–794. 12 indexed citations
2.
Moore, Donald C., et al.. (2019). Impact of Body Mass Index on the Incidence of Bortezomib-induced Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 20(3). 168–173. 6 indexed citations
3.
Singhi, Eric K., Donald C. Moore, & Alaa Muslimani. (2018). Metastatic Soft Tissue Sarcomas: A Review Of Treatment and New Pharmacotherapies.. PubMed. 43(7). 410–429. 34 indexed citations
4.
Muslimani, Alaa, et al.. (2013). Pulmonary Infiltrates in Acute Myeloid Leukemia During Induction Treatment. American Journal of Clinical Oncology. 37(4). 377–383. 5 indexed citations
5.
Muslimani, Alaa, et al.. (2011). How we treat tumor lysis syndrome.. PubMed. 25(4). 369–75. 12 indexed citations
6.
Nair, Girish B., et al.. (2011). A cirrhotic patient with spontaneous intramuscular hematoma due to primary hyperfibrinolysis.. PubMed. 9(3). 249–52. 7 indexed citations
7.
Muslimani, Alaa, et al.. (2010). Incidence of central port failure among patients receiving bevacizumab.. Journal of Clinical Oncology. 28(15_suppl). e19579–e19579. 1 indexed citations
8.
Muslimani, Alaa, et al.. (2010). Langerhans/Dendritic Cell Sarcoma Arising From Hairy Cell Leukemia. Clinical Lymphoma Myeloma & Leukemia. 10(3). E39–E39. 1 indexed citations
9.
Muslimani, Alaa, et al.. (2009). Venous Thromboembolism in Lymphoma. American Journal of Clinical Oncology. 32(5). 521–523. 5 indexed citations
10.
Muslimani, Alaa, et al.. (2009). Aromatase Inhibitor–Related Musculoskeletal Symptoms: Is Preventing Osteoporosis the Key to Eliminating These Symptoms?. Clinical Breast Cancer. 9(1). 34–38. 33 indexed citations
11.
Muslimani, Alaa, et al.. (2008). The Utility of 18-F-Fluorodeoxyglucose Positron Emission Tomography in Evaluation of Bone Marrow Involvement by Non-Hodgkin Lymphoma. American Journal of Clinical Oncology. 31(5). 409–412. 26 indexed citations
12.
Muslimani, Alaa, Madappa N. Kundranda, Timothy Spiro, et al.. (2008). Venous Thromboembolism (VTE) in Patients (pts.) with Monoclonal Gammopathy of Undetermined Significance (MGUS). Blood. 112(11). 5340–5340. 1 indexed citations
13.
Muslimani, Alaa, et al.. (2008). Primary Pleuropulmonary Synovial Sarcoma. Clinical Lung Cancer. 9(5). 257–261. 32 indexed citations
14.
Muslimani, Alaa, et al.. (2008). Aromatase inhibitor (AI) related musculoskeletal (MS) symptoms: Is preventing osteoporosis the key to eliminating these symptoms?. Journal of Clinical Oncology. 26(15_suppl). 9554–9554. 1 indexed citations
15.
Muslimani, Alaa, et al.. (2007). Recurrent Bronchial Epithelial-Myoepithelial Carcinoma After Local Therapy. Clinical Lung Cancer. 8(6). 386–388. 15 indexed citations
16.
Kundranda, Madappa N., Alaa Muslimani, Hamed Daw, & Timothy P. Spiro. (2007). Complete Remission of Metastatic Carcinoma of the Prostate with Bicalutamide Withdrawal. Clinical Genitourinary Cancer. 5(6). 401–402. 1 indexed citations
17.
Muslimani, Alaa, Madappa N. Kundranda, & Hamed Daw. (2007). Chronic anemia due to parvovirus B19 infection in a patient with multiple myeloma.. PubMed. 5(1). 48–9; discussion 49. 2 indexed citations
18.
Muslimani, Alaa, et al.. (2007). Venous Thromboembolism in Lymphoma: How Effectively Are We Treating Patients?.. Blood. 110(11). 1878–1878. 1 indexed citations
19.
Muslimani, Alaa, et al.. (2006). Primary adenoid cystic carcinoma of the breast: case report and review of the literature. PubMed. 3(1). 17–17. 27 indexed citations
20.
Muslimani, Alaa, et al.. (2006). Immune heparin‐induced thrombocytopenia resulting from preceding exposure to heparin catheter flushes. American Journal of Hematology. 82(7). 652–655. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026